10 research outputs found

    Evidence for effective interventions to reduce mental Healthrelated stigma and discrimination in the medium and long term : Systematic review

    Get PDF
    Publisher Copyright: Copyright © 2015 The Royal College of Psychiatrists, unless otherwise stated.Background Most research on interventions to counter stigma and discrimination has focused on shortterm outcomes and has been conducted in highincome settings. Aims To synthesise what is known globally about effective interventions to reduce mental illnessbased stigma and discrimination, in relation first to effectiveness in the medium and long term (minimum 4 weeks), and second to interventions in lowand middleincome countries (LMICs). Method We searched six databases from 1980 to 2013 and conducted a multilanguage Google search for quantitative studies addressing the research questions. Effect sizes were calculated from eligible studies where possible, and narrative syntheses conducted. Subgroup analysis compared interventions with and without social contact. Results Eighty studies (n = 422 653) were included in the review. For studies with medium or longterm followup (72, of which 21 had calculable effect sizes) median standardised mean differences were 0.54 for knowledge and-0.26 for stigmatising attitudes. Those containing social contact (direct or indirect) were not more effective than those without. The 11 LMIC studies were all from middleincome countries. Effect sizes were rarely calculable for behavioural outcomes or in LMIC studies. Conclusions There is modest evidence for the effectiveness of antistigma interventions beyond 4 weeks followup in terms of increasing knowledge and reducing stigmatising attitudes. Evidence does not support the view that social contact is the more effective type of intervention for improving attitudes in the medium to long term. Methodologically strong research is needed on which to base decisions on investment in stigmareducing interventions.Peer reviewe

    Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study

    Get PDF
    BACKGROUND: In May 2020, the ACCESS (The vACCine covid-19 monitoring readinESS) project was launched to prepare real-world monitoring of COVID-19 vaccines. Within this project, this study aimed to generate background incidence rates of 41 adverse events of special interest (AESI) to contextualize potential safety signals detected following administration of COVID-19 vaccines. METHODS: A dynamic cohort study was conducted using a distributed data network of 10 healthcare databases from 7 European countries (Italy, Spain, Denmark, The Netherlands, Germany, France and United Kingdom) over the period 2017 to 2020. A common protocol (EUPAS37273), common data model, and common analytics programs were applied for syntactic, semantic and analytical harmonization. Incidence rates (IR) for each AESI and each database were calculated by age and sex by dividing the number of incident cases by the total person-time at risk. Age-standardized rates were pooled using random effect models according to the provenance of the events. FINDINGS: A total number of 63,456,074 individuals were included in the study, contributing to 211.7 million person-years. A clear age pattern was observed for most AESIs, rates also varied by provenance of disease diagnosis (primary care, specialist care). Thrombosis with thrombocytopenia rates were extremely low ranging from 0.06 to 4.53/100,000 person-years for cerebral venous sinus thrombosis (CVST) with thrombocytopenia (TP) and mixed venous and arterial thrombosis with TP, respectively. INTERPRETATION: Given the nature of the AESIs and the setting (general practitioners or hospital-based databases or both), background rates from databases that show the highest level of completeness (primary care and specialist care) should be preferred, others can be used for sensitivity. The study was designed to ensure representativeness to the European population and generalizability of the background incidence rates. FUNDING: The project has received support from the European Medicines Agency under the Framework service contract nr EMA/2018/28/PE

    Étude de terrain sur les troubles de l’alimentation et des conduites alimentaires dans le cadre du dĂ©veloppement de la CIM 11

    No full text
    Dans le cadre du dĂ©veloppement de la classification internationale des maladies (CIM-11), les groupes de travail ont dĂ©veloppĂ© des propositions avec pour objectif d’amĂ©liorer l’utilitĂ© clinique de la classification. Ces propositions sont testĂ©es via la plateforme internet « RĂ©seau Mondial de Pratique Clinique (RMPC) » permettant de conduire Ă  des Ă©tudes cliniques Ă©lectroniques dans les langues officielles de l’OMS, dont le français. Cette Ă©tude s’intĂ©resse aux catĂ©gories diagnostiques des troubles de l’alimentation et des conduites alimentaires (TCA). Des nouveaux diagnostics ont Ă©tĂ© proposĂ©s tels que le trouble d’hyperphagie et le trouble d’évitement et de restriction de l’apport alimentaire. – évaluer l’impact des changements spĂ©cifiques des TCA entre la CIM-10 et la CIM-11 auprĂšs des membres francophones du RMPC ; – évaluer la validitĂ©, l’utilitĂ© clinique des nouvelles propositions et l’accord inter-juges des participants. Étude mixte, internationale, conduite par internet auprĂšs des membres francophones du RMPC. Membres du RMPC maĂźtrisant le français (environ 1000 professionnels) et exerçant une activitĂ© clinique. La population cible recevra un email d’invitation. Les participants seront amenĂ©s Ă  lire deux vignettes puis Ă  poser des diagnostics et Ă  rĂ©pondre Ă  des questions complĂ©mentaires, en se basant sur la CIM-10 ou la CIM-11 qu’ils auront reçu de façon alĂ©atoire. Les vignettes reprĂ©senteront des cas cliniques rĂ©els et reflĂšteront les changements spĂ©cifiques entre la CIM-10 et la CIM-11. Elles seront ainsi prĂ©sentĂ©es par pair (8 pairs possibles). Comparaisons : – interparticipants portant sur l’utilisation du systĂšme diagnostique (10 ou 11) et l’attribution du diagnostic en fonction des changements spĂ©cifiques ; – intra-participant sur l’évaluation des pairs de vignettes. Cette Ă©tude doit permettre d’évaluer les nouvelles propositions CIM en français, en tenant compte des spĂ©cificitĂ©s culturelles et linguistiques de la francophonie

    Increasing burden of viral bronchiolitis in the pediatric intensive care unit:an observational study

    Get PDF
    Purpose: Viral bronchiolitis is a major cause of pediatric intensive care unit (PICU) admission. Insight in the trends of bronchiolitis-associated PICU admissions is limited, but imperative for future PICU resource and capacity planning. Materials and methods: We retrospectively studied trends in PICU admissions for bronchiolitis in six European sites, including three full national registries, between 2000 and 2019 and calculated population-based estimates per 100,000 children where appropriate. Information concerning risk factors for severe disease and use of invasive mechanical ventilation was also collected when available. Results: In total, there were 15,606 PICU admissions for bronchiolitis. We observed an increase in the annual number, rate and estimates per 100,000 children of PICU admissions for bronchiolitis at all sites over the last two decades, while the proportion of patients at high risk for severe disease remained relatively stable. Conclusions: The international increased burden of bronchiolitis for the PICU is concerning, and warrants further international attention and investigation.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

    Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study

    No full text
    Purpose: Viral bronchiolitis is a major cause of pediatric intensive care unit (PICU) admission. Insight in the trends of bronchiolitis-associated PICU admissions is limited, but imperative for future PICU resource and capacity planning. Materials and methods: We retrospectively studied trends in PICU admissions for bronchiolitis in six European sites, including three full national registries, between 2000 and 2019 and calculated population-based estimates per 100,000 children where appropriate. Information concerning risk factors for severe disease and use of invasive mechanical ventilation was also collected when available. Results: In total, there were 15,606 PICU admissions for bronchiolitis. We observed an increase in the annual number, rate and estimates per 100,000 children of PICU admissions for bronchiolitis at all sites over the last two decades, while the proportion of patients at high risk for severe disease remained relatively stable. Conclusions: The international increased burden of bronchiolitis for the PICU is concerning, and warrants further international attention and investigation

    Accessibility of psychiatric vocabulary: An international study about schizophrenia essential features

    No full text
    37"."nonenoneAskevis-Leherpeux F.; Hazo J.-B.; Agoub M.; Baleige A.; Barikova V.; Benmessaoud D.; Brunet F.; Carta M.-G.; Castelpietra G.; Crepaz-Keay D.; Daumerie N.; Demassiet V.; Fontaine A.; Grigutyte N.; Guernut M.; Kishore J.; Kiss M.; Koenig M.; Laporta M.; Layoussif E.; Limane Y.; Lopez M.; Mura G.; Pelletier J.-F.; Raharinivo M.; Reed G.; Richa S.; Robles-Garcia R.; Saxena S.; Skourteli M.; Tassi F.; Stona A.-C.; Thevenon C.; Triantafyllou M.; Vasilopoulos F.; Wooley S.; Roelandt J.-L.Askevis-Leherpeux, F.; Hazo, J. -B.; Agoub, M.; Baleige, A.; Barikova, V.; Benmessaoud, D.; Brunet, F.; Carta, M. -G.; Castelpietra, G.; Crepaz-Keay, D.; Daumerie, N.; Demassiet, V.; Fontaine, A.; Grigutyte, N.; Guernut, M.; Kishore, J.; Kiss, M.; Koenig, M.; Laporta, M.; Layoussif, E.; Limane, Y.; Lopez, M.; Mura, G.; Pelletier, J. -F.; Raharinivo, M.; Reed, G.; Richa, S.; Robles-Garcia, R.; Saxena, S.; Skourteli, M.; Tassi, F.; Stona, A. -C.; Thevenon, C.; Triantafyllou, M.; Vasilopoulos, F.; Wooley, S.; Roelandt, J. -L

    Estimating transmission parameters for respiratory syncytial virus and predicting the impact of maternal and pediatric vaccination

    No full text
    Background Respiratory syncytial virus (RSV) is a leading cause of respiratory tract illness in young children and a major cause of hospital admissions globally. Methods Here we fit age-structured transmission models with immunity propagation to data from the Netherlands (2012–2017). Data included nationwide hospitalizations with confirmed RSV, general practitioner (GP) data on attendance for care from acute respiratory infection, and virological testing of acute respiratory infections at the GP. The transmission models, equipped with key parameter estimates, were used to predict the impact of maternal and pediatric vaccination. Results Estimates of the basic reproduction number were generally high (R0 > 10 in scenarios with high statistical support), while susceptibility was estimated to be low in nonelderly adults (<10% in persons 20–64 years) and was higher in older adults (≄65 years). Scenario analyses predicted that maternal vaccination reduces the incidence of infection in vulnerable infants (<1 year) and shifts the age of first infection from infants to young children. Conclusions Pediatric vaccination is expected to reduce the incidence of infection in infants and young children (0–5 years), slightly increase incidence in 5 to 9-year-old children, and have minor indirect benefits

    How service users and carers understand, perceive, rephrase, and communicate about “depressive episode” and “schizophrenia” diagnoses: an international participatory research

    Get PDF
    Background: For ICD-11, the WHO emphasized the clinical utility of communication and the need to involve service users and carers in the revision process. Aims: The objective was to assess whether medical vocabulary was accessible, which kinds of feelings it activated, whether and how users and carers would like to rephrase terms, and whether they used diagnosis to talk about mental health experiences. Method: An innovative protocol focused on two diagnoses (depressive episode and schizophrenia) was implemented in 15 different countries. The same issues were discussed with users and carers: understanding, feelings, rephrasing, and communication. Results: Most participants reported understanding the diagnoses, but associated them with negative feelings. While the negativity of “depressive episode” mostly came from the concept itself, that of “schizophrenia” was largely based on its social impact and stigmatization associated with “mental illness”. When rephrasing “depressive episode”, a majority kept the root “depress*”, and suppressed the temporal dimension or renamed it. Almost no one suggested a reformulation based on “schizophrenia”. Finally, when communicating, no one used the phrase “depressive episode”. Some participants used words based on “depress”, but no one mentioned “episode”. Very few used “schizophrenia”. Conclusion: Data revealed a gap between concepts and emotional and cognitive experiences. Both professional and experiential language and knowledge have to be considered as complementary. Consequently, the ICD should be co-constructed by professionals, service users, and carers. It should take the emotional component of language, and the diversity of linguistic and cultural contexts, into account
    corecore